These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22991977)

  • 1. Vitamin B₁₂ derivatives as activators of soluble guanylyl cyclase.
    ó Proinsias K; Gryko DT; Hisaeda Y; Martin E; Sessler JL; Gryko D
    J Med Chem; 2012 Oct; 55(20):8943-7. PubMed ID: 22991977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the rescue of oxidized soluble guanylate cyclase by the activator cinaciguat.
    Surmeli NB; Marletta MA
    Chembiochem; 2012 May; 13(7):977-81. PubMed ID: 22474005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new small molecule inhibitor of soluble guanylate cyclase.
    Mota F; Gane P; Hampden-Smith K; Allerston CK; Garthwaite J; Selwood DL
    Bioorg Med Chem; 2015 Sep; 23(17):5303-10. PubMed ID: 26264842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase.
    Martin F; Baskaran P; Ma X; Dunten PW; Schaefer M; Stasch JP; Beuve A; van den Akker F
    J Biol Chem; 2010 Jul; 285(29):22651-7. PubMed ID: 20463019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1.
    Martin NI; Derbyshire ER; Marletta MA
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4938-41. PubMed ID: 17587571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acrylamide analog as a novel nitric oxide-independent soluble guanylyl cyclase activator.
    Nakane M; Kolasa T; Chang R; Miller LN; Moreland RB; Brioni JD
    J Pharmacol Sci; 2006 Oct; 102(2):231-8. PubMed ID: 17050951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation and loss of heme in soluble guanylyl cyclase from Manduca sexta.
    Fritz BG; Hu X; Brailey JL; Berry RE; Walker FA; Montfort WR
    Biochemistry; 2011 Jul; 50(26):5813-5. PubMed ID: 21639146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
    Hoffmann LS; Schmidt PM; Keim Y; Schaefer S; Schmidt HH; Stasch JP
    Br J Pharmacol; 2009 Jul; 157(5):781-95. PubMed ID: 19466990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotidyl cyclase activity of soluble guanylyl cyclase α1β1.
    Beste KY; Burhenne H; Kaever V; Stasch JP; Seifert R
    Biochemistry; 2012 Jan; 51(1):194-204. PubMed ID: 22122229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the signaling helix coiled-coil domain of the beta1 subunit of the soluble guanylyl cyclase.
    Ma X; Beuve A; van den Akker F
    BMC Struct Biol; 2010 Jan; 10():2. PubMed ID: 20105301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-particle EM reveals the higher-order domain architecture of soluble guanylate cyclase.
    Campbell MG; Underbakke ES; Potter CS; Carragher B; Marletta MA
    Proc Natl Acad Sci U S A; 2014 Feb; 111(8):2960-5. PubMed ID: 24516165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble guanylate cyclase: an old therapeutic target re-visited.
    Hobbs AJ
    Br J Pharmacol; 2002 Jul; 136(5):637-40. PubMed ID: 12086972
    [No Abstract]   [Full Text] [Related]  

  • 13. Soluble guanylate cyclase is activated differently by excess NO and by YC-1: resonance Raman spectroscopic evidence.
    Ibrahim M; Derbyshire ER; Soldatova AV; Marletta MA; Spiro TG
    Biochemistry; 2010 Jun; 49(23):4864-71. PubMed ID: 20459051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potentiation of activation of soluble guanylate cyclase by YC-1, NO-donors and increase of the synergistic effect of YC-1 on NO-dependent activation of the enzyme by 1,2,3-triazolyl-1,2,5-oxadiazole derivatives].
    Severina IS; Pyatakova NV; Shchegolev AY; Rozhkov VY; Batog LV; Makhova NN
    Biomed Khim; 2015; 61(6):705-11. PubMed ID: 26716741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking allosteric propagation with HX-MS.
    Braun AP; Schriemer DC
    Structure; 2014 Apr; 22(4):512-4. PubMed ID: 24717559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Structure, regulation and functions of particulate guanylyl cyclase type A].
    Mitkiewicz M
    Postepy Hig Med Dosw (Online); 2015 Apr; 69():457-68. PubMed ID: 25897107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme-dependent and independent soluble guanylate cyclase activators and vasodilation.
    Priviero FB; Webb RC
    J Cardiovasc Pharmacol; 2010 Sep; 56(3):229-33. PubMed ID: 20571429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress.
    Zhou Z; Pyriochou A; Kotanidou A; Dalkas G; van Eickels M; Spyroulias G; Roussos C; Papapetropoulos A
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1763-71. PubMed ID: 18757489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure/activity relationships of (M)ANT- and TNP-nucleotides for inhibition of rat soluble guanylyl cyclase α1β1.
    Dove S; Danker KY; Stasch JP; Kaever V; Seifert R
    Mol Pharmacol; 2014 Apr; 85(4):598-607. PubMed ID: 24470063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and regulation of soluble guanylate cyclase.
    Derbyshire ER; Marletta MA
    Annu Rev Biochem; 2012; 81():533-59. PubMed ID: 22404633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.